Contrast-enhanced mammography-guided biopsy: technical feasibility and first outcomes.

ABSTRACT:

Objectives

To evaluate the feasibility of contrast-enhanced mammography (CEM)-guided biopsy at Hospital del Mar, a Spanish university hospital.

Methods

We retrospectively reviewed all consecutive women with a suspicious enhancing finding eligible for CEM-guided biopsy, who were prospectively enrolled in a pre-marketing clinical validation and feasibility study (October 2019 to September 2021). CEM-guided biopsy is a stereotactic-based procedure that, by using intravenous iodinated contrast media administration and dual-energy acquisition, provides localisation of enhancing lesions. All the biopsies were performed using a vacuum-assisted device. We collected procedural characteristics (patient position and type of approach), and histopathological results. Feasibility endpoint

SUBMITTER: Alcantara R 

PROVIDER: S-EPMC9755098 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature